Literature DB >> 28149915

Myeloid-derived suppressor cell, arginase-1, IL-17 and cl-CD95L: an explosive cocktail in lupus?

Robin J Flynn1, Patrick Legembre2.   

Abstract

Entities:  

Year:  2016        PMID： 28149915      PMCID： PMC5233543          DOI： 10.21037/atm.2016.12.35

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  20 in total

Review 1.  Effector T-cell subsets in systemic lupus erythematosus: update focusing on Th17 cells.

Authors:  Min S Shin; Naeun Lee; Insoo Kang
Journal:  Curr Opin Rheumatol       Date:  2011-09       Impact factor: 5.006

2.  Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming.

Authors:  J Wolfers; A Lozier; G Raposo; A Regnault; C Théry; C Masurier; C Flament; S Pouzieux; F Faure; T Tursz; E Angevin; S Amigorena; L Zitvogel
Journal:  Nat Med       Date:  2001-03       Impact factor: 53.440

Review 3.  Tumor necrosis factor receptor and Fas signaling mechanisms.

Authors:  D Wallach; E E Varfolomeev; N L Malinin; Y V Goltsev; A V Kovalenko; M P Boldin
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

Review 4.  CD95-mediated cell signaling in cancer: mutations and post-translational modulations.

Authors:  Sébastien Tauzin; Laure Debure; Jean-François Moreau; Patrick Legembre
Journal:  Cell Mol Life Sci       Date:  2011-11-01       Impact factor: 9.261

5.  OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response.

Authors:  Clément Jacquemin; Nathalie Schmitt; Cécile Contin-Bordes; Yang Liu; Priya Narayanan; Julien Seneschal; Typhanie Maurouard; David Dougall; Emily Spence Davizon; Hélène Dumortier; Isabelle Douchet; Loïc Raffray; Christophe Richez; Estibaliz Lazaro; Pierre Duffau; Marie-Elise Truchetet; Liliane Khoryati; Patrick Mercié; Lionel Couzi; Pierre Merville; Thierry Schaeverbeke; Jean-François Viallard; Jean-Luc Pellegrin; Jean-François Moreau; Sylviane Muller; Sandy Zurawski; Robert L Coffman; Virginia Pascual; Hideki Ueno; Patrick Blanco
Journal:  Immunity       Date:  2015-06-09       Impact factor: 31.745

Review 6.  Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected.

Authors:  Douglas Marvel; Dmitry I Gabrilovich
Journal:  J Clin Invest       Date:  2015-07-13       Impact factor: 14.808

7.  GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

Authors:  David H Munn; Madhav D Sharma; Babak Baban; Heather P Harding; Yuhong Zhang; David Ron; Andrew L Mellor
Journal:  Immunity       Date:  2005-05       Impact factor: 31.745

Review 8.  Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.

Authors:  Katherine H Parker; Daniel W Beury; Suzanne Ostrand-Rosenberg
Journal:  Adv Cancer Res       Date:  2015-05-12       Impact factor: 6.242

9.  CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.

Authors:  Oliver M Steinmetz; Jan-Eric Turner; Hans-Joachim Paust; Matthias Lindner; Anett Peters; Kirstin Heiss; Joachim Velden; Helmut Hopfer; Susanne Fehr; Thorsten Krieger; Catherine Meyer-Schwesinger; Tobias N Meyer; Udo Helmchen; Hans-Willi Mittrücker; Rolf A K Stahl; Ulf Panzer
Journal:  J Immunol       Date:  2009-09-04       Impact factor: 5.422

10.  Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis.

Authors:  John T Pesce; Thirumalai R Ramalingam; Margaret M Mentink-Kane; Mark S Wilson; Karim C El Kasmi; Amber M Smith; Robert W Thompson; Allen W Cheever; Peter J Murray; Thomas A Wynn
Journal:  PLoS Pathog       Date:  2009-04-10       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.